Pfizer, which has struck a nearly $2 billion deal with the US government to deliver 100 million doses of a COVID-19 vaccine developed in collaboration with its German partner BioNTech, is hoping to seek regulatory approval for a vaccine "as early as October" this year and have a vaccine on the market by year end.
from IndiaTV World: Google News Feed https://ift.tt/30EeKdd
0 Comments
Please do not enter any spam link in the comment box.